Ping Li

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Optical Coherence Tomography

Top Venues

Current cancer drug targets

Journal of oncology

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Yiqi Du, Fenglin Zhang, Panling Xu, Ping Li
Brucine Inhibits Proliferation of Pancreatic Ductal Adenocarcinoma through PI3K/AKT Pathway-induced Mitochondrial Apoptosis. Current cancer drug targets 24 (7) (2024)
Yiqi Du, Fenglin Zhang, Panling Xu, Ping Li
Brucine Inhibits Proliferation of Pancreatic Ductal Adenocarcinoma through PI3K/AKT Pathway-induced Mitochondrial Apoptosis. Current cancer drug targets (2024)
Yiqi Du, Fenglin Zhang, Panling Xu, Ping Li
Brucine Inhibits Proliferation of Pancreatic Ductal Adenocarcinoma through PI3K/AKT Pathway-induced Mitochondrial Apoptosis. Current cancer drug targets 24 (7) (2024)
Xin Sun, Panling Xu, Fengli Zhang, Ting Sun, Haili Jiang, Mei Zhang, Ping Li
Study on Mechanism of Yiqi Yangyin Jiedu Recipe Inhibiting Triple Negative Breast Cancer Growth: A Network Pharmacology and In Vitro Verification. Journal of oncology 2022 (2022)
Meng-Ran Xu, Peng-Fei Wei, Ming-Zhu Suo, Yi Hu, Weiping Ding, Li Su, Yao-Dong Zhu, Wan-Ji Song, Guan-Hao Tang, Mei Zhang, Ping Li
Brucine Suppresses Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cell Line MDA-MB-231. BioMed research international 2019 (2019)